NCT05718492
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jan 2023); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Objective Response Rate (ORR)
Timeframe: 2-years Followed up
Progress Free Survival (PFS)
Timeframe: 2-years Followed up
Secondary (3)
Overall Survival (OS)
Tumor local control
Adverse Events (AEs)
Arms and interventions
HAICExperimental
Treated by HAIC alone.
Procedures: digital subtraction angiography.
Drugs: FOLFOX (oxaliplatin , leucovorin , fluorouracil , and fluorouracil )
Sites
1 site in 1 country
- Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, China